Top

Published in:

01-12-2015 | Original Communication

Long-term effect on dystonia after pallidal deep brain stimulation (DBS) in three members of a family with a THAP1 mutation

Authors: P. Krause, N. Brüggemann, S. Völzmann, A. Horn, A. Kupsch, G.-H. Schneider, K. Lohmann, A. Kühn

Published in: Journal of Neurology | Issue 12/2015

Abstract

Deep brain stimulation (DBS) of the globus pallidus internus (GPi) is an established treatment in patients with severe dystonia. However, factors predicting outcome are largely unknown and motor improvement in DYT6 patients after DBS has been reported to be poorer as compared to, e.g., DYT1 patients. Here, we report the course of clinical improvement for up to 11 years of pallidal DBS in three male patients belonging to the same family with early-onset generalized or segmental dystonia due to a heterozygous THAP1 gene mutation (DYT6). All patients showed an initial effective response to pallidal DBS with a mean of 56.9 ± 11.7 % improvement in the Burke–Fahn–Marsden Dystonia motor and 45.5 ± 22.4 % in the disability score at 1-year follow-up. The long-term outcome of pallidal DBS was favorable in two patients (39, 67 % motor improvement, respectively). Our findings demonstrate that motor improvement is variable and may depend on disease severity, disease duration, and clinical presentation. Overall, our observation supports pallidal DBS as an important treatment option in patients with DYT6 dystonia.

Available only for authorised users

Albanese A, Bhatia K, Bressman SB et al (2013) Phenomenology and classification of dystonia: a consensus update. Mov Disord 28:863–873PubMedCentralCrossRefPubMed

Ozelius LJ, Hewett JW, Page CE et al (1997) The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein. Nat Genet 17:40–48CrossRefPubMed

Fuchs T, Gavarini S, Saunders-Pullman R et al (2009) Mutations in the THAP1 gene are responsible for DYT6 primary torsion dystonia. Nat Genet 41:286–288CrossRefPubMed

Bonetti M, Barzaghi C, Brancati F et al (2009) Mutation screening of the DYT6/THAP1 gene in Italy. Mov Disord Off J Mov Disord Soc 24:2424–2427CrossRef

Bressman SBRD, Fuchs T, Heiman G, Ozelius LJ, Saunders-Pullman R (2009) Mutations in THAP1 (DYT6) in early-onset dystonia: a genetic screening study. Lancet Neurol 8:441–446PubMedCentralCrossRefPubMed

Djarmati A, Schneider SA, Lohmann K et al (2009) Mutations in THAP1 (DYT6) and generalised dystonia with prominent spasmodic dysphonia: a genetic screening study. Lancet Neurol 8:447–452CrossRefPubMed

Kupsch A, Benecke R, Muller J et al (2006) Pallidal deep-brain stimulation in primary generalized or segmental dystonia. New Engl J Med 355:1978–1990CrossRefPubMed

Mueller J, Skogseid IM, Benecke R et al (2008) Pallidal deep brain stimulation improves quality of life in segmental and generalized dystonia: results from a prospective, randomized sham-controlled trial. Mov Disord Off J Mov Dis Soc 23:131–134CrossRef

Vidailhet M, Vercueil L, Houeto J-L et al (2007) Bilateral, pallidal, deep-brain stimulation in primary generalised dystonia: a prospective 3 year follow-up study. Lancet Neurol 6:223–229CrossRefPubMed

10.

Volkmann J, Wolters A, Kupsch A et al (2012) Pallidal deep brain stimulation in patients with primary generalised or segmental dystonia: 5-year follow-up of a randomised trial. Lancet Neurol 11:1029–1038CrossRefPubMed

11.

Coubes P, Cif L, El Fertit H et al (2004) Electrical stimulation of the globus pallidus internus in patients with primary generalized dystonia: long-term results. J Neurosurg 101:189–194CrossRefPubMed

12.

Isaias IU, Alterman RL, Tagliati M (2008) Outcome predictors of pallidal stimulation in patients with primary dystonia: the role of disease duration. Brain J Neurol 131:1895–1902CrossRef

13.

Markun LC, Starr PA, Air EL, Marks WJ Jr, Volz MM, Ostrem JL (2012) Shorter disease duration correlates with improved long-term deep brain stimulation outcomes in young-onset DYT1 dystonia. Neurosurgery 71:325–330CrossRefPubMed

14.

Andrews C, Aviles-Olmos I, Hariz M, Foltynie T (2010) Which patients with dystonia benefit from deep brain stimulation? A metaregression of individual patient outcomes. J Neurol Neurosurg Psychiatry 81:1383–1389CrossRefPubMed

15.

Borggraefe I, Mehrkens JH, Telegravciska M, Berweck S, Botzel K, Heinen F (2010) Bilateral pallidal stimulation in children and adolescents with primary generalized dystonia—report of six patients and literature-based analysis of predictive outcomes variables. Brain Dev 32:223–228CrossRefPubMed

16.

Tagliati M, Shils J, Sun C, Alterman R (2004) Deep brain stimulation for dystonia. Expert Rev Med Devices 1:33–41CrossRefPubMed

17.

Groen JL, Ritz K, Contarino MF et al (2010) DYT6 dystonia: mutation screening, phenotype, and response to deep brain stimulation. Mov Disord 25:2420–2427CrossRefPubMed

18.

Panov F, Tagliati M, Ozelius LJ et al (2012) Pallidal deep brain stimulation for DYT6 dystonia. J Neurol Neurosurg Psychiatry 83:182–187CrossRefPubMed

19.

Zittel S, Moll CK, Bruggemann N et al (2010) Clinical neuroimaging and electrophysiological assessment of three DYT6 dystonia families. Mov Off J Mov Disord Soc 25:2405–2412CrossRef

20.

Jech RBM, Křepelová A, Urgošík D, Havránková P, Růžička E (2011) DYT 6—a novel THAP1 mutation with excellent effect on pallidal DBS. Mov Off J Mov Disord Soc 26:924–925CrossRef

21.

França S, Linhares P, Rosas MJ, Volkmann J (2014) Pallidal deep brain stimulation in DYT6: significant long-term improvement of dystonia and disability. Mov Disord Clin Pract 1(2):118–120CrossRef

22.

Bruggemann N, Kuhn A, Schneider SA et al (2015) Short- and long-term outcome of chronic pallidal neurostimulation in monogenic isolated dystonia. Neurology 84:895–903CrossRefPubMed

23.

Lohmann K, Uflacker N, Erogullari A et al (2012) Identification and functional analysis of novel THAP1 mutations. Eur J Hum Genet 20:171–175PubMedCentralCrossRefPubMed

24.

Silberstein P, Kuhn AA, Kupsch A et al (2003) Patterning of globus pallidus local field potentials differs between Parkinson’s disease and dystonia. Brain J Neurol 126:2597–2608CrossRef

25.

Cif L, Vasques X, Gonzalez V et al (2010) Long-term follow-up of DYT1 dystonia patients treated by deep brain stimulation: an open-label study. Mov Off J Mov Disord Soc 25:289–299CrossRef

26.

Vidailhet M, Vercueil L, Houeto JL et al (2005) Bilateral deep-brain stimulation of the globus pallidus in primary generalized dystonia. New Engl J Med 352:459–467CrossRefPubMed

27.

Grips E, Blahak C, Capelle HH et al (2007) Patterns of reoccurrence of segmental dystonia after discontinuation of deep brain stimulation. J Neurol Neurosurg Psychiatry 78:318–320PubMedCentralCrossRefPubMed

28.

Vidailhet M, Jutras MF, Grabli D, Roze E (2013) Deep brain stimulation for dystonia. J Neurol Neurosurg Psychiatry 84:1029–1042CrossRefPubMed

29.

Barow E, Neumann WJ, Brucke C et al (2014) Deep brain stimulation suppresses pallidal low frequency activity in patients with phasic dystonic movements. Brain J Neurol 137:3012–3024CrossRef

30.

Ruge D, Cif L, Limousin P et al (2011) Shaping reversibility? Long-term deep brain stimulation in dystonia: the relationship between effects on electrophysiology and clinical symptoms. Brain J Neurol 134:2106–2115CrossRef

Title: Long-term effect on dystonia after pallidal deep brain stimulation (DBS) in three members of a family with a THAP1 mutation
Authors: P. Krause
N. Brüggemann
S. Völzmann
A. Horn
A. Kupsch
G.-H. Schneider
K. Lohmann
A. Kühn
Publication date: 01-12-2015
Publisher: Springer Berlin Heidelberg
Published in: Journal of Neurology / Issue 12/2015
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-015-7908-z

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Long-term effect on dystonia after pallidal deep brain stimulation (DBS) in three members of a family with a THAP1 mutation

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 12/2015

Vitamin D supplementation and systemic inflammation in relapsing-remitting multiple sclerosis

Powerhouse failure and oxidative damage in autosomal recessive spastic ataxia of Charlevoix-Saguenay

Neuro-ophthalmology and neuro-otology update

Thrombectomy assisted by carotid stenting in acute ischemic stroke management: benefits and harms

Dissecting IWG-2 typical and atypical Alzheimer’s disease: insights from cerebrospinal fluid analysis

Variants in KIF1A gene in dominant and sporadic forms of hereditary spastic paraparesis